Search details
1.
Early Infliximab Clearance Predicts Remission in Children with Crohn's Disease.
Dig Dis Sci
; 68(5): 1995-2005, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36562887
2.
P010 Precision Dosing Tool Forecasts Trough Infliximab and Associates With Disease Status in Inflammatory Bowel Diseases.
Am J Gastroenterol
; 116(Suppl 1): S3, 2021 Dec 01.
Article
in English
| MEDLINE | ID: mdl-37461930
3.
Efficacy of dashboard driven dosing of infliximab in inflammatory bowel disease patients; a randomized controlled trial.
Scand J Gastroenterol
; 56(2): 145-154, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-33290108
4.
Optimization of infliximab therapy in inflammatory bowel disease using a dashboard approach-an Indian experience.
Eur J Clin Pharmacol
; 77(1): 55-62, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-32803288
5.
Designing clinical trials in paediatric inflammatory bowel diseases: a PIBDnet commentary.
Gut
; 69(1): 32-41, 2020 01.
Article
in English
| MEDLINE | ID: mdl-30979718
6.
Population pharmacokinetics of pevonedistat alone or in combination with standard of care in patients with solid tumours or haematological malignancies.
Br J Clin Pharmacol
; 85(11): 2568-2579, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31355467
7.
Effect of alisertib, an investigational aurora a kinase inhibitor on the QTc interval in patients with advanced malignancies.
Invest New Drugs
; 36(2): 240-247, 2018 04.
Article
in English
| MEDLINE | ID: mdl-28819760
8.
Global population pharmacokinetics of the investigational Aurora A kinase inhibitor alisertib in cancer patients: rationale for lower dosage in Asia.
Br J Clin Pharmacol
; 84(1): 35-51, 2018 Jan.
Article
in English
| MEDLINE | ID: mdl-28891222
9.
Exposure-response characterization of tofacitinib efficacy in moderate to severe ulcerative colitis: Results from a dose-ranging phase 2 trial.
Br J Clin Pharmacol
; 84(6): 1136-1145, 2018 06.
Article
in English
| MEDLINE | ID: mdl-29377257
10.
Converting from Transdermal to Buccal Formulations of Buprenorphine: A Pharmacokinetic Meta-Model Simulation in Healthy Volunteers.
Pain Med
; 19(10): 1988-1996, 2018 10 01.
Article
in English
| MEDLINE | ID: mdl-29036723
11.
A Randomized Study Evaluating Oral Fusidic Acid (CEM-102) in Combination With Oral Rifampin Compared With Standard-of-Care Antibiotics for Treatment of Prosthetic Joint Infections: A Newly Identified Drug-Drug Interaction.
Clin Infect Dis
; 63(12): 1599-1604, 2016 Dec 15.
Article
in English
| MEDLINE | ID: mdl-27682068
12.
Appropriateness of Testing for Anti-Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results.
Clin Gastroenterol Hepatol
; 14(9): 1302-9, 2016 09.
Article
in English
| MEDLINE | ID: mdl-27189916
13.
Correction to: Optimization of infliximab therapy in inflammatory bowel disease using a dashboard approach-an Indian experience.
Eur J Clin Pharmacol
; 77(2): 273-274, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-32886180
14.
The Pharmacokinetics of Biologics: A Primer.
Dig Dis
; 33 Suppl 1: 61-69, 2015.
Article
in English
| MEDLINE | ID: mdl-26367860
15.
Population pharmacokinetic analysis of voriconazole and anidulafungin in adult patients with invasive aspergillosis.
Antimicrob Agents Chemother
; 58(8): 4718-26, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24913161
16.
Population pharmacokinetic-pharmacodynamic analysis of voriconazole and anidulafungin in adult patients with invasive aspergillosis.
Antimicrob Agents Chemother
; 58(8): 4727-36, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24914120
17.
Population pharmacokinetics of azithromycin and chloroquine in healthy adults and paediatric malaria subjects following oral administration of fixed-dose azithromycin and chloroquine combination tablets.
Malar J
; 13: 36, 2014 Jan 29.
Article
in English
| MEDLINE | ID: mdl-24472224
18.
"Getting the Dose Right"-Revisiting the Topic With Focus on Biologic Agents.
Clin Pharmacol Ther
; 2024 Apr 28.
Article
in English
| MEDLINE | ID: mdl-38680029
19.
Application of a Precision-Dosing Model to a Real-World Cohort of Patients on Infliximab Maintenance Therapy: Drug Usage and Cost Analysis.
J Clin Pharmacol
; 64(4): 399-409, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-37964618
20.
Tumor growth inhibition modeling in patients with second line biliary tract cancer and first line non-small cell lung cancer based on bintrafusp alfa trials.
CPT Pharmacometrics Syst Pharmacol
; 13(1): 143-153, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38087967